Specimen validity testing is the set of laboratory checks that confirms a urine sample is genuine human urine and has not been diluted, adulterated, or substituted before it is analyzed for drugs. Every drug test regulated by the U.S. Department of Transportation includes it as a mandatory first step, and many private-employer programs use it too. The lab measures biological markers like creatinine and pH, screens for foreign chemicals, and flags anything inconsistent with normal human biology. Depending on what it finds, the consequences range from a simple recollection to permanent removal from safety-sensitive work.
What the Laboratory Measures
Four core checks run on every specimen before any drug analysis begins.
Creatinine
Creatinine is a waste product the kidneys filter at a fairly predictable rate, which makes it a reliable indicator that a sample is actually urine. Under DOT rules, the lab must measure creatinine on every specimen, and if the concentration falls below 20 mg/dL, it also checks specific gravity to determine whether the sample is dilute or substituted.1eCFR. 49 CFR 40.87 – What Validity Tests Must Laboratories Conduct on Primary Specimens Creatinine at or above 20 mg/dL raises no flag. Between 2 and 20 mg/dL, paired with low specific gravity, the sample is reported as dilute. Below 2 mg/dL, the specimen likely isn’t human urine at all and gets reported as substituted.2GovInfo. 49 CFR Part 40 – Section 40.88
Specific Gravity
Specific gravity measures how concentrated the dissolved particles in urine are compared with plain water. It works alongside creatinine. A specimen with specific gravity above 1.0010 but below 1.0030, combined with creatinine between 2 and 20 mg/dL, is dilute. If specific gravity drops to 1.0010 or below, or rises to 1.0200 or above, while creatinine is below 2 mg/dL, the sample is substituted.2GovInfo. 49 CFR Part 40 – Section 40.88 Both the initial and confirmatory tests on two separate portions must agree before a substituted finding is reported.
pH
Normal human urine falls roughly between pH 4.5 and 9.0. Values below 3.0 or at 11.0 or higher are reported as adulterated, because no naturally produced urine reaches those extremes. Values in the borderline zones (between 3.0 and 4.5, or between 9.0 and 11.0) trigger an invalid result, meaning something is off but the lab can’t say precisely what.3SAMHSA. Medical Review Officer Guidance Manual for Federal Workplace Drug Testing Programs
Oxidizing Adulterants
Labs must also run at least one test targeting oxidizing chemicals on every specimen.1eCFR. 49 CFR 40.87 – What Validity Tests Must Laboratories Conduct on Primary Specimens These are the chemicals people add to destroy drug metabolites. If anything unusual shows up during screening (abnormal color, odd instrument response, interference with drug testing), additional validity tests are run to identify the substance.
Adulterants Labs Look For
People who try to tamper with a sample tend to reach for a short list of chemicals, and labs know exactly what to look for.
Nitrites break down drug metabolites before the lab can identify them. A nitrite concentration at or above 500 mcg/mL is reported as adulterated. Between 200 and 500 mcg/mL, the specimen falls into the invalid range: suspicious but not conclusive.
Oxidizing agents such as bleach and pyridinium chlorochromate (sold in some commercial “detox” products) chemically destroy drug molecules in the cup. Labs detect chromium (VI), the active component in pyridinium chlorochromate, using colorimetric tests with a 50 mcg/mL cutoff. Bleach and other halogen-based oxidizers are caught through general oxidant screening.
Glutaraldehyde and surfactants take a different route: rather than destroying drug molecules, they interfere with the enzymes used in immunoassay screening and can cause false negatives. Surfactant concentrations at or above 100 mcg/mL flag the specimen. Glutaraldehyde is detected through aldehyde-specific colorimetric testing.
None of these chemicals occur naturally in human urine, so their presence is strong evidence of tampering. Labs use both initial and confirmatory testing on separate portions before reporting an adulterated result.
Checks at the Collection Site
Validity screening starts before the sample ever reaches the lab. The collector reads the temperature strip on the collection container within four minutes of receiving the specimen; the acceptable range is 90–100°F (32–38°C).4eCFR. 49 CFR 40.65 – What Does the Collector Check for When the Employee Presents a Urine Specimen A sample outside that range suggests it was carried in or swapped rather than freshly produced. The collector also confirms the specimen holds at least 45 mL of urine and inspects it for unusual color, foreign objects, or odor.
When something looks wrong (out-of-range temperature, unusual appearance, or suspicious behavior during the collection) the collector must immediately conduct a second collection under direct observation.5U.S. Department of Transportation. 49 CFR Part 40 Section 40.67 – When and How Is a Directly Observed Urine Collection Conducted Directly observed collections are also mandatory for all return-to-duty and follow-up tests. Declining one counts as a refusal to test, which carries the same consequences as a verified positive.
Result Categories the Lab Reports
After validity and drug testing, the lab reports the specimen under one of several categories, and each triggers a different chain of events.
- Negative. All validity checks passed and no drugs above cutoff. No further action.
- Negative-dilute. No drugs detected, but creatinine and specific gravity show the sample was more watered down than expected.
- Positive-dilute. The sample was dilute, but drugs were still detected above cutoffs. The employer treats it as a verified positive.
- Adulterated. The specimen contains a foreign chemical or has a pH so extreme (below 3.0 or at or above 11.0) that it cannot be naturally produced urine.
- Substituted. Creatinine below 2 mg/dL with specific gravity at or below 1.0010 or at or above 1.0200. The specimen doesn’t meet the basic characteristics of human urine.
- Invalid. Something interfered with testing, but the lab can’t identify what. Includes borderline pH zones, unidentified interfering substances, and physical properties that prevent reliable analysis.
- Rejected for testing. A procedural problem (wrong container, broken seal, incomplete paperwork) made the specimen unsuitable before testing began.
The lab reports the actual numerical values (creatinine concentration, specific gravity, pH, identified adulterants) alongside each finding, so the Medical Review Officer has concrete data to work with.6eCFR. 49 CFR Part 40 Subpart F – Drug Testing Laboratories
When a Result Counts as a Refusal to Test
Under DOT rules, a verified adulterated or substituted result is not merely a failed test. It is treated as a refusal to test, the most serious outcome in the DOT framework.7eCFR. 49 CFR 40.191 – What Is a Refusal to Take a DOT Drug Test, and What Are the Consequences Admitting to the collector or MRO that you tampered with or substituted your specimen qualifies as a refusal, as does declining a directly observed collection when one is required.
A refusal triggers the same consequences as a DOT drug violation: immediate removal from safety-sensitive duties, mandatory completion of the return-to-duty process with a Substance Abuse Professional, and reporting requirements that follow the worker across employers. One detail catches people off guard. Those consequences cannot be overturned by an arbitrator, a union grievance, or a state court; federal DOT regulations govern the personnel actions the employer must take.7eCFR. 49 CFR 40.191 – What Is a Refusal to Take a DOT Drug Test, and What Are the Consequences For FMCSA-regulated commercial drivers, refusals must be reported to the Drug and Alcohol Clearinghouse, a national database other employers check before hiring. FAA-regulated employers and MROs must report refusals within two working days.8U.S. Department of Transportation. What Employers Need to Know About DOT Drug and Alcohol Testing
The 72-Hour Right to a Split Specimen Test
When your sample was collected, it was divided into two bottles: a primary (A) specimen and a split (B) specimen. If the MRO notifies you of a verified positive, adulterated, or substituted result, you have 72 hours from that notification to request testing of the split specimen.9U.S. Department of Transportation. 49 CFR Part 40 Section 40.171 The request can be verbal or written. If you miss the window, you may still get the test if you can show that a serious injury, illness, lack of actual notice, inability to reach the MRO, or other unavoidable circumstance prevented a timely request. The split goes to a different HHS-certified laboratory for independent analysis. This is the primary safeguard against lab error, so if you believe the result is wrong, act inside the 72 hours.
The Medical Review Officer’s Verification
Lab results do not go straight to the employer. A Medical Review Officer, a licensed physician trained in drug testing, reviews every non-negative result first. When the report shows an adulterated or substituted specimen, the MRO must contact the employee for a verification interview.10eCFR. 49 CFR 40.145 – On What Basis Does the MRO Verify Test Results Involving Adulteration or Substitution The MRO explains the findings and gives the employee a chance to offer a legitimate medical explanation. The burden of proof is entirely on the employee. For an adulterated specimen, they must show the adulterant entered the sample through a physiological process. For a substituted specimen, they must show they could naturally produce urine with those creatinine and specific gravity levels.
The employee needs to present this information during the interview. The MRO can extend the deadline by up to five days when there is a reasonable basis to believe relevant evidence is coming. If the MRO finds no credible explanation, the result is reported to the employer as a verified refusal to test. If the MRO thinks a legitimate explanation may exist, they can refer the employee to a specialist, though neither the MRO nor the employer is required to pay for that evaluation.10eCFR. 49 CFR 40.145 – On What Basis Does the MRO Verify Test Results Involving Adulteration or Substitution
How Employers Handle Dilute Results
Dilute specimens are far more common than adulterated or substituted ones. Sometimes a donor simply drank a lot of water before the test. How the employer responds depends on whether drugs were also detected.
A positive-dilute is straightforward. The employer treats it as a verified positive, and no retest is allowed based solely on the dilution.11eCFR. 49 CFR 40.197 – What Does the Employer Do When the MRO Informs the Employer That a Test Result Is Dilute
A negative-dilute takes more judgment. If creatinine was very low (at or above 2 mg/dL but at or below 5 mg/dL), the MRO directs the employer to recollect immediately under direct observation.12eCFR. 49 CFR 40.155 – What Does the MRO Do When a Negative or Positive Test Result Is Also Dilute If creatinine was above 5 mg/dL, the employer may order one retest but is not required to. That retest cannot be directly observed unless a separate basis for observation exists. The employer must apply the same policy to every employee in a given testing category; selective retesting is not permitted.11eCFR. 49 CFR 40.197 – What Does the Employer Do When the MRO Informs the Employer That a Test Result Is Dilute If the retest comes back negative-dilute again, the employer must accept the result. The cycle stops at two.
Who These Rules Apply To
The DOT requires specimen validity testing on every regulated drug test under 49 CFR Part 40. The regulation covers safety-sensitive workers across multiple DOT agencies, including commercial truck drivers, airline pilots, transit operators, pipeline workers, and railroad employees. Every collection type is covered: pre-employment, random, post-accident, reasonable suspicion, return-to-duty, and follow-up. The cutoff values and testing procedures come from the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs, and HHS-certified laboratories perform all federally regulated testing so the standard is the same across agencies. Private employers outside DOT authority may choose to include specimen validity testing in their programs, and many do, but they are not required to.